Substance / Medication

Dihydroxyacetone

Overview

Active Ingredient
dihydroxyacetone
RxNorm CUI
3430

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Protection against visible light by dihydroxyacetone in erythropoietic protoporphyria.
Heerfordt Ida M, Philipsen Peter A, Lerche Catharina M et al. · Photodiagnosis Photodyn Ther · 2023
PMID: 36690194RCT
Quantitation of Dihydroxyacetone in Australian Leptospermum Nectar via High-Performance Liquid Chromatography.
Norton Amanda M, McKenzie Leah N, Brooks Peter R et al. · J Agric Food Chem · 2015
PMID: 26140295Observational
Production of Gluconobacter oxydans cells from low-cost culture medium for conversion of glycerol to dihydroxyacetone.
Wei Shenghua, Song Qingxun, Wei Dongzhi · Prep Biochem Biotechnol · 2007
PMID: 17454822Observational
Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase.
Diao Feici, Li Shu, Tian Yang et al. · Proc Natl Acad Sci U S A · 2007
PMID: 17600090ObservationalFull text (PMC)
In situ hybridization of dihydroxyacetone phosphate acyltransferase, the regulating enzyme involved in plasmalogen biosynthesis.
André Agnès, Tessier Christian, Brétillon Lionel et al. · Brain Res Mol Brain Res · 2005
PMID: 15893598Observational
Phosphoenolpyruvate- and ATP-dependent dihydroxyacetone kinases: covalent substrate-binding and kinetic mechanism.
Garcia-Alles Luis F, Siebold Christian, Nyffeler Therese Lüthi et al. · Biochemistry · 2004
PMID: 15476397Observational
A mechanism of covalent substrate binding in the x-ray structure of subunit K of the Escherichia coli dihydroxyacetone kinase.
Siebold Christian, García-Alles Luis Fernando, Erni Bernhard et al. · Proc Natl Acad Sci U S A · 2003
PMID: 12813127ObservationalFull text (PMC)
Optimization of the microbial synthesis of dihydroxyacetone from glycerol with Gluconobacter oxydans.
Hekmat D, Bauer R, Fricke J · Bioprocess Biosyst Eng · 2003
PMID: 14598160Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dihydroxyacetone (substance)
SNOMED CT
14809000
UMLS CUI
C0012322
RxNorm CUI
3430

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.